EP3592355
KX2-391/KX-01 til notkunar í meðhöndlun á geislunarhyrningu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.3.2018EP published:
10.12.2025EP application number:
18764980.1
EP translation filed:
16.2.2026Grant published:
11.3.2026EPO information:
European Patent Register
Max expiry date:
11.3.2038Expiry date:
11.3.2027Next due date:
31.3.2027
Title in English:
KX2-391/KX-01 FOR USE IN THE TREATMENT OF ACTINIC KERATOSISLanguage of the patent:
English
Timeline
Today
12.3.2018EP application
10.12.2025EP Publication
16.2.2026Translation submitted
11.3.2026Registration published
11.3.2027Expires
Owner
Name:
ATNX SPV, LLCAddress:
161 Bay Street, Suite 5000, Toronto, Ontario M5J 2S1, CA
Inventor
Name:
KWAN, Min-Fun RudolfAddress:
Summit, New Jersey 07901, US
Name:
LAU, Johnson Yiu-NamAddress:
Houston, TX 77057, US
Name:
KRAMER, E. DouglasAddress:
Stamford, Connecticut 06905, US
Name:
CUTLER, David LawrenceAddress:
Moorestown, New Jersey 08057, US
Name:
FANG, JaneAddress:
Newport Beach, California 92660, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201762469889 PDate:
10.3.2017Country:
US
Classification
Categories:
A61K 31/5377, A61P 17/00, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.3.2026
Expires: 11.3.2027
Payer: Árnason Faktor ehf.